News

News-Medical.Net on MSN7d
Long term steroid use raises risk of adrenal insufficiency
Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal ...
MedPage Today on MSN1d
First Oral Therapy for Rare Adrenal Gland Tumors Gets Green Light From FDA
The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and children 12 years or older with locally advanced, unresectable, or metastatic ...
PharmExec2d
FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma
Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...
Labmate Online4d
Long-term steroid use linked to adrenal gland impairment: real-world evidence
Treatment with steroid tablets for longer than three months has been shown to increase the likelihood of diagnosis with ...
Pharmabiz2d
Merck’s Welireg receives US FDA approval to treat locally advanced, unresectable or metastatic pheochromocytoma or paraganglioma
Rahway, New Jersey Friday, May 16, 2025, 13:00 Hrs [IST] ...